In contrast, a study on antithrombin III showed a trend towards a reduction in 90-day mortality in the high-risk SAPS II stratum, which was not observed at 28 days [ 8 ].
← all excerpts
Residual rates of mortality in patients with severe sepsis: a fatality or a new challenge?
1
—
—